Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis

Takeo Yoshihara, Shinichiro Shinzaki, Tetsuji Naka, Hideki Iijima, Yoshito Hayashi, Unknown, Takahiro Inoue, Yoshiki Tsujii, Ryotaro Uema, Yuriko Otake-Kasamoto, Mizuki Tani, Takahiro Amano, Taku Tashiro, Akiko Asakura, Yuko Sakakibara, Takuya Yamada, Satoshi Hiyama, Tsutomu Nishida, Kaori Ishiguro, Yuji Baba, Tetsuo Takehara

Open source

DOI: 10.1093/crocol/otag084
Published: 2026-07
Container: Crohn’s & Colitis 360
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/crocol/otag084,
  title = {Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis},
  author = {Takeo Yoshihara and Shinichiro Shinzaki and Tetsuji Naka and Hideki Iijima and Yoshito Hayashi and Unknown and Takahiro Inoue and Yoshiki Tsujii and Ryotaro Uema and Yuriko Otake-Kasamoto and Mizuki Tani and Takahiro Amano and Taku Tashiro and Akiko Asakura and Yuko Sakakibara and Takuya Yamada and Satoshi Hiyama and Tsutomu Nishida and Kaori Ishiguro and Yuji Baba and Tetsuo Takehara},
  year = {2026},
  journal = {Crohn’s \&amp; Colitis 360},
  doi = {10.1093/crocol/otag084},
  url = {https://doi.org/10.1093/crocol/otag084}
}

RIS

TY  - JOUR
TI  - Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis
AU  - Takeo Yoshihara
AU  - Shinichiro Shinzaki
AU  - Tetsuji Naka
AU  - Hideki Iijima
AU  - Yoshito Hayashi
AU  - Unknown
AU  - Takahiro Inoue
AU  - Yoshiki Tsujii
AU  - Ryotaro Uema
AU  - Yuriko Otake-Kasamoto
AU  - Mizuki Tani
AU  - Takahiro Amano
AU  - Taku Tashiro
AU  - Akiko Asakura
AU  - Yuko Sakakibara
AU  - Takuya Yamada
AU  - Satoshi Hiyama
AU  - Tsutomu Nishida
AU  - Kaori Ishiguro
AU  - Yuji Baba
AU  - Tetsuo Takehara
PY  - 2026
JO  - Crohn’s &amp; Colitis 360
DO  - 10.1093/crocol/otag084
UR  - https://doi.org/10.1093/crocol/otag084
ER  -

APA

Yoshihara, T., Shinzaki, S., Naka, T., Iijima, H., Hayashi, Y., Unknown, Inoue, T., Tsujii, Y., Uema, R., Otake-Kasamoto, Y., Tani, M., Amano, T., Tashiro, T., Asakura, A., Sakakibara, Y., Yamada, T., Hiyama, S., Nishida, T., Ishiguro, K., Baba, Y., & Takehara, T. (2026). Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis. Crohn’s & Colitis 360. https://doi.org/10.1093/crocol/otag084

Source records

crossref · retrieved 2026-09-26T11:13:28.455Z